Pfizer/BioNTech to seek emergency vaccine approval in US Friday

Washington (AFP) – An emergency use authorization request for the Covid-19 vaccine developed by Pfizer and BioNTech was expected to be filed with the FDA Friday, the US government and BioNTech’s co-founder said.This type of authorization is temporary or conditional and is granted in response to an emergency situation such as a pandemic — and may be revoked or modified if new efficacy or safety data emerge later.”Pfizer’s partner BioNTech has announced that tomorrow, they intend to file for emergency use authorization at the FDA,” health secretary Alex Azar told a press conference Thursday in …

Read More

HEDGE accordingly